U.S. stocks rose Wednesday, building on Tuesday's gains, as Brexit fears dissipated. Analysts said Brexit shouldn't affect U.S. economic growth. 'Our view is that it's a domestic issue,' said David Lebovitz, global market strategist at JPMorgan Asset Management, based in New York. 'This really matters for the UK and Europe - both economies are going to slow down as a result.' Shares of Shire (SHPG) were on the rise after its ADHD treatment trial met various standards. The treatment will now be resubmitted to the Food and Drug Administration. Meanwhile, personal income in May rose 0.2 percent month-over-month, missing estimates of 0.3 percent. Consumer spending rose 0.4 percent, matching estimates. The core personal consumption expenditure price index gained 0.2 percent during the month, in-line with estimates. TheStreet's Scott Gamm reports from Wall Street.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.